L-Nutra

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, L-Nutra sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials 1 currently recruiting 3 completed upper quartile by trial count

L-Nutra: 5 sponsored US clinical trials, 1 recruiting.

L-Nutra sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Autophagy, with 1 trials.

Upper-quartile sponsor footprint

L-Nutra sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

5 total, page 1 of 1

RECRUITING NA

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

NCT06376604
ACTIVE NOT RECRUITING NA

Fasting Mimicking Diet and Autophagy

NCT06115551
COMPLETED NA

Effect of Fasting-Mimicking Diet on Skin Health

NCT05564624
COMPLETED NA

Effects of Fast Bar on Intermittent Fasting

NCT04790552
COMPLETED NA

Effects of Fast Bar on Physiological Fasting

NCT04499599

Therapeutic Areas

Autophagy 1
Calorie Deficiency 1
Chemotherapy Effect 1
Diet 1
Fasting, Intermittent 1
Cancer - Ovarian 1

What is open in the L-Nutra pipeline

1 recruiting of 5 indexed (20% open); 3 completed (60%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Autophagy (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

L-Nutra: open-pipeline peers nationwide

Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.

L-Nutra sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 4.95.05.055.05.05.1 0%5%10%15%20%25% Total trials Recruiting share L-Nutra4YouandMeAbbott Rapid DxAccess Business GroupAcera SurgicalAlign TechnologyAltruBioAlvernia UniversityAmazentis
L-Nutra sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

L-Nutra sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 trials (± recruiting share)

Sponsors near 20% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this L-Nutra page

5 registered trials is a research-attention snapshot, not an endorsement of L-Nutra or any single study.

  • 1 of L-Nutra's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autophagy is the condition L-Nutra studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autophagy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

L-Nutra pipeline card: 5 registered trials from official public datasets.Report a data error.